In NAFLD and NASH, insulin resistance and inflammatory cytokines, such as TNF-α and IL-6, are key drivers, with miR-122 and miR-34a playing significant roles in lipid metabolism and inflammation [15]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.